Pharmacologic management of behavioral instability in medically ill pediatric patients

Current Opinion in Pediatrics
Michael R Cummings, Bruce D Miller

Abstract

Behavioral instability in children and adolescents is a vexing problem faced by many clinicians. This dilemma is magnified when it presents in a child with an acute medical condition. Effective treatment in these cases with medications may help to reduce morbidity and facilitate appropriate medical care for the underlying condition. There are many reviews, but few studies examine the treatment of behavioral instability in the pediatric population. There are even fewer that address behavioral instability in the presence of a comorbid medical condition. Many effective agents may worsen a given condition or interfere with the treatment of that condition. There are no prospective studies addressing this issue. Many psychotropic medications must be considered when treating behavioral instability in medically ill children. Antihistamines, benzodiazepines, and antipsychotics may be of particular benefit. Definitive research is lacking and necessary to develop appropriate clinical guidelines. This article considers the most current literature and provides an overall summary of the topic.

References

Mar 1, 1990·Journal of the American Academy of Child and Adolescent Psychiatry·J T StewartW B Lyles
Feb 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·C Lang, D Remington
Jan 1, 1996·The Journal of Burn Care & Rehabilitation·R L BrownG D Warden
Mar 21, 1998·The American Journal of Psychiatry·L W RobertsT McCarty
Oct 28, 1998·Journal of Clinical Child Psychology·O G Bukstein, D J Kolko
May 7, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·N D RyanJ M Perel
May 7, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·M A RiddleJ M Swanson
Jan 12, 2000·Journal of Child and Adolescent Psychopharmacology·M WudarskyJ L Rapoport
Feb 24, 2001·Journal of Child and Adolescent Psychopharmacology·A MartinJ F Leckman
Nov 3, 2001·The American Journal of Psychiatry·A H Glassman, J T Bigger
Nov 28, 2001·JAMA : the Journal of the American Medical Association·E KollerP M Doraiswamy
Jan 22, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Marilyn Bartolo Benoit
Feb 9, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Kim J MastersUNKNOWN American Academy of Child and Adolescent Psychiatry
Mar 12, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Daniel F ConnorRichard H Melloni
Jan 25, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Sarah B SchurPeter S Jensen
Jan 25, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Elizabeth PappadopulosPeter S Jensen
Oct 15, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Susan dosReisUNKNOWN Maryland Youth Practice Improvement Committee
Oct 30, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Linmarie SikichJeffrey A Lieberman

❮ Previous
Next ❯

Citations

Dec 18, 2010·Paediatric Drugs·Loretta Sonnier, Drew Barzman
Oct 16, 2007·Pediatric Clinics of North America·Courtney J WusthoffDaniel J Licht
Dec 20, 2016·Journal of Child and Adolescent Psychopharmacology·Lauren T SchumacherJames G MacKenzie
Aug 28, 2020·Journal of Child and Adolescent Psychopharmacology·Orit PeledNoa Benaroya-Milshtein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here